A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer (Q30438645)
scientific article
Language:
(P31) (Q13442814)
(P304) 161-167
(P407) (Q1860)
(P433) 2
(P478) 87
(P577) Monday, July 1, 2002
(P921) (Q269829)
(Q212961)
(P1433) (Q326309)
(P1476) "A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer" (language: en)
(P2093) S R Bramhall
J Schulz
J Nemunaitis
P D Brown
M Baillet
J A C Buckels
(P2860) (Q36644664)
(Q28366568)
(Q36641139)
(Q33329807)
(Q33329493)
(Q33585599)
(Q33328191)
(Q40980720)
(Q41111506)
(Q29547565)
(Q41117672)
(Q41451390)
(Q41072619)
(Q36138631)
(Q34732138)
(Q24312733)
(Q33491184)
(Q39695304)
(Q43693195)
(Q51094647)
(Q52242595)
(Q51133785)
(Q55064253)
(Q43686273)
(Q73828612)
(Q69243992)
(Q61819266)
(Q71939391)
(Q84106417)
(Q57561877)
(Q62065473)
(Q60043767)
(Q64915286)
(Q71528572)
other details